
|Articles|June 24, 2009
Gene therapies
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.
Advertisement
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
3
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
4
The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD
5







